IRIDEX CORP
Last verified 2026-05-06. JSON
| Total raised | $10.0M |
|---|---|
| Latest round | Funding round, $10.0M, 2025-03-19 |
| Founded | 1989 |
| Headquarters | Mountain View, CA |
| Industry | healthcare |
| Stage | unknown |
| Website | iridex.com |
Iridex manufactures ophthalmic laser systems used to treat retinal disease and glaucoma in eye-care practices worldwide. It serves retina specialists, glaucoma surgeons, and comprehensive eye doctors operating in-office and surgical settings. Its proprietary MicroPulse technology delivers laser energy in short pulses that are fovea-friendly and minimize collateral retinal damage, an approach competing continuous-wave lasers cannot replicate.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-03-19 | Funding round | $10.0M | undisclosed |
Detected tech stack
IIS 10.0, Microsoft ASP.NET 4.0.30319, YouTube, Google Tag Manager, Slimbox 2, jQuery UI, Plesk, DNN, HubSpot, cdnjs, Cookiebot, Vercel Speed Insights
Provenance
| Fact | Status | Basis |
|---|---|---|
| Funding round, $10.0M | sourced | SEC EDGAR named as publisher. Document, retrieved 2026-09-25. |
| Total raised $10.0M | sourced | SEC EDGAR named as publisher. Document, retrieved 2026-09-25. |
| Company existence | self-reported | iridex.com, read 2026-05-06 |
| Description | self-reported | iridex.com, read 2026-05-06 |
Change history
| Date | Fact | Change | Basis |
|---|---|---|---|
| 2026-09-25Latest round: seed, $10.0M, 2025-03-19 → Funding round, $10.0M, 2025-03-19, SEC EDGAR, document, retrieved 2026-09-25 | Latest round | seed, $10.0M, 2025-03-19 → Funding round, $10.0M, 2025-03-19 | SEC EDGAR, document, retrieved 2026-09-25 |
| 2026-09-25Round: attributed → sourced, SEC EDGAR, document, retrieved 2026-09-25 | Round | attributed → sourced | SEC EDGAR, document, retrieved 2026-09-25 |
Records begin 2026-09-24. All changes